Akiko Ohshita

Locoregional immunotherapy of malignant effusion from colorectal cancer using the streptococcal preparation OK-432 plus Interleukin-2

Yoshiyuki Yamaguchi, Eiji Miyahara, Akiko Ohshita et al. · British Journal of Cancer · 2003 · 26 citations · Full text

Medicine, Immunology, Oncology +16

Postoperative immunosuppression cascade and immunotherapy using lymphokine-activated killer cells for patients with esophageal cancer: Possible application for compensatory anti-inflammatory response syndrome

Yoshiyuki Yamaguchi, Jun Hihara, Katsuji Hironaka et al. · Oncology Reports · 2006 · 21 citations · Full text

Medicine, Immunology, Oncology +15

Feasibility study of adoptive immunotherapy for metastatic lung tumors using peptide-pulsed dendritic cell-activated killer (PDAK) cells.

Yoshiyuki Yamaguchi, Koji Ohta, Yoshiharu Kawabuchi et al. · PubMed · 2005 · 19 citations

Medicine, Immunology, Oncology +16

Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment

Yoshiyuki Yamaguchi, Akiko Ohshita, Yoshiharu Kawabuchi et al. · International Journal of Oncology · 2004 · 16 citations

Medicine, Immunology, Oncology +17

HER2-specific cytotoxic activity of lymphokine-activated killer cells in the presence of trastuzumab.

Yoshiyuki Yamaguchi, Katsuji Hironaka, Makoto Okawaki et al. · PubMed · 2005 · 15 citations

Medicine, Immunology, Oncology +11